Abiopharma

Walker & Dunlop Arranges $105 Million Loan to Refinance Luxury Raleigh Community

United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026

All Three Independent Proxy Advisors Recommend Ingles Markets Shareholders Vote for Rory A. Held

Parsons Demand Response Technology to Optimize and Enable Los Angeles Department of Water & Power’s Operations and Strategic Plan

U.S. GoldMining Mobilizes 2026 Exploration Program Targeting District-Scale Potential at the Whistler Project, Alaska

PermRock Royalty Trust Declares Monthly Cash Distribution

Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering

No Questions Received From Shareholders Relating To The AGM To Be Held On 30 April 2026

Holdings of interested parties/officers as of 31.3.26

STLA INVESTOR NOTICE: Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law